Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego
19 janv. 2022 07h00 HE
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
Recro Reports Inducement Grants For New Staff
06 janv. 2022 16h05 HE
|
Recro Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 07h00 HE
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021
02 nov. 2021 16h05 HE
|
Recro Pharma, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Recro Pharma, Inc.
04 juin 2018 16h12 HE
|
Federman & Sherwood
OKLAHOMA CITY, June 04, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on May 31, 2018, a class action lawsuit was filed in the United States District Court for the Eastern District...